Captrust Financial Advisors Reduces Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Captrust Financial Advisors decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 56.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,097 shares of the pharmacy operator's stock after selling 53,276 shares during the period. Captrust Financial Advisors' holdings in Walgreens Boots Alliance were worth $368,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Inlet Private Wealth LLC raised its holdings in shares of Walgreens Boots Alliance by 1.9% in the 2nd quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator's stock valued at $578,000 after purchasing an additional 900 shares in the last quarter. Capital Investment Counsel Inc raised its stake in Walgreens Boots Alliance by 6.6% in the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator's stock worth $186,000 after buying an additional 950 shares in the last quarter. Continuum Advisory LLC lifted its holdings in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock worth $30,000 after buying an additional 1,020 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Walgreens Boots Alliance by 1.6% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator's stock valued at $795,000 after acquiring an additional 1,038 shares in the last quarter. Finally, Sequoia Financial Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 4.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator's stock valued at $226,000 after acquiring an additional 1,063 shares during the period. Institutional investors own 58.59% of the company's stock.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating on the stock in a research report on Friday, August 30th. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating on the stock in a report on Wednesday, September 4th. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a research note on Friday, October 11th. Royal Bank of Canada lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a "sector perform" rating for the company in a research note on Wednesday, December 4th. Finally, Evercore ISI upped their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an "in-line" rating in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $12.58.

Walgreens Boots Alliance Stock Performance

WBA stock traded up $0.66 during trading on Friday, hitting $10.39. 38,948,975 shares of the company traded hands, compared to its average volume of 24,339,830. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The stock's 50-day simple moving average is $9.27 and its 200 day simple moving average is $10.72. The company has a market cap of $8.98 billion, a PE ratio of -1.04, a P/E/G ratio of 1.36 and a beta of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm's revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the business earned $0.67 earnings per share. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were paid a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 9.62%. Walgreens Boots Alliance's dividend payout ratio is currently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.